TITLE

Investigating cellular identity and manipulating cell fate using induced pluripotent stem cells

AUTHOR(S)
Tohru Sugawara; Koichiro Nishino; Akihiro Umezawa; Hidenori Akutsu
PUB. DATE
February 2012
SOURCE
Stem Cell Research & Therapy;2012, Vol. 3 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Induced pluripotent stem (iPS) cells, obtained from reprogramming somatic cells by ectopic expression of a defined set of transcription factors or chemicals, are expected to be used as differentiated cells for drug screening or evaluations of drug toxicity and cell replacement therapies. As pluripotent stem cells, iPS cells are similar to embryonic stem (ES) cells in morphology and marker expression. Several types of iPS cells have been generated using combinations of reprogramming molecules and/or small chemical compounds from different types of tissues. A comprehensive approach, such as global gene or microRNA expression analysis and whole genomic DNA methylation profiling, has demonstrated that iPS cells are similar to their embryonic counterparts. Considering the substantial variation among iPS cell lines reported to date, the safety and therapeutic implications of these differences should be thoroughly evaluated before they are used in cell therapies. Here, we review recent research defining the concept of standardization for iPS cells, their ability to differentiate and the identity of the differentiated cells.
ACCESSION #
90398021

 

Related Articles

  • In Vitro Modeling of Paraxial Mesodermal Progenitors Derived from Induced Pluripotent Stem Cells. Sakurai, Hidetoshi; Sakaguchi, Yasuko; Shoji, Emi; Nishino, Tokiko; Maki, Izumi; Sakai, Hiroshi; Hanaoka, Kazunori; Kakizuka, Akira; Sehara-Fujisawa, Atsuko // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    Induced pluripotent stem (iPS) cells are generated from adult somatic cells by transduction of defined factors. Given their unlimited proliferation and differentiation potential, iPS cells represent promising sources for cell therapy and tools for research and drug discovery. However, systems...

  • Induced pluripotent stem cells in research and therapy. Hoon-Koon Teoh; Soon-Keng Cheong // Malaysian Journal of Pathology;Jun2012, Vol. 34 Issue 1, p1 

    Induced pluripotent stem cells (iPSC) are derived from human somatic cells through ectopic expression of transcription factors. This landmark discovery has been considered as a major development towards patient-specific iPSC for various biomedical applications. Unlimited self renewal capacity,...

  • Carbon emissions: Learn from China's local pilot schemes. Zhu, Xufeng // Nature;10/3/2013, Vol. 502 Issue 7469, p38 

    The article focuses on a research which reveals that the elimination of the protein Mbd3 allows reprogramming of the induced pluripotent stem (iPS) cells. It states that cellular identity is achieved by tran­scription factor and mentions four stem-cell regulators that can be injected into...

  • Challenges in the clinical application of induced pluripotent stem cells. Sipp, Douglas // Stem Cell Research & Therapy;2010, Vol. 1 Issue 1, p1 

    The advent of human induced pluripotent stem cells has been heralded as a major breakthrough in the study of pluripotent stem cells, for these cells have yielded fundamental insights into the reprogrammability of somatic cell fates, but also because of their seemingly great promise in...

  • Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors. Maza, Itay; Caspi, Inbal; Zviran, Asaf; Chomsky, Elad; Rais, Yoach; Viukov, Sergey; Geula, Shay; Buenrostro, Jason D; Weinberger, Leehee; Krupalnik, Vladislav; Hanna, Suhair; Zerbib, Mirie; Dutton, James R; Greenleaf, William J; Massarwa, Rada; Novershtern, Noa; Hanna, Jacob H // Nature Biotechnology;Jul2015, Vol. 33 Issue 7, p769 

    Somatic cells can be transdifferentiated to other cell types without passing through a pluripotent state by ectopic expression of appropriate transcription factors. Recent reports have proposed an alternative transdifferentiation method in which fibroblasts are directly converted to various...

  • Experimental approaches for the generation of induced pluripotent stem cells. Sommer, Cesar A.; Mostoslavsky, Gustavo // Stem Cell Research & Therapy;2010, Vol. 1 Issue 3, p1 

    Derivation of autologous induced pluripotent stem cells (iPSCs) through direct reprogramming of easily accessible somatic cells holds the potential to transform the field of regenerative medicine. Since Takahashi and Yamanaka's groundbreaking study describing the generation of iPSCs by...

  • Stem cells: Sweetening pluripotency. Donner, Amy // Nature Chemical Biology;Jul2012, Vol. 8 Issue 7, p602 

    The article offers information on the transformation of somatic cells into induced pluripotent stem cells by the combination of transcription factors which includes octamer binding transcription factor 4 (OCT-4) and SOX2.

  • An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs. Menon, Siddharth; Shailendra, Siny; Renda, Andrea; Longaker, Michael; Quarto, Natalina // International Journal of Molecular Sciences;2016, Vol. 17 Issue 1, p141 

    Stem cells are classified into embryonic stem cells and adult stem cells. An evolving alternative to conventional stem cell therapies is induced pluripotent stem cells (iPSCs), which have a multi-lineage potential comparable to conventionally acquired embryonic stem cells with the additional...

  • Advances and applications of induced pluripotent stem cells. Pietronave, Stefano; Prat, Maria // Canadian Journal of Physiology & Pharmacology;Mar2012, Vol. 90 Issue 3, p317 

    Direct reprogramming of somatic cells into pluripotent cells is an emerging technology for creating patient-specific cells, and potentially opens new scenarios in medical and pharmacological fields. From the discovery of Shinya Yamanaka, who first obtained pluripotent cells from fibroblasts by...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics